Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fahad Alnouri

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Current Vascular Pharmacology|March 7, 2022
Identification of Novel and Known LDLR Variants Triggering Severe Familial Hypercholesterolemia in Saudi FamiliesFahad Alnouri, Faisal A Al-Allaf, Mohammad Athar, et al.
Atherosclerosis|March 28, 2026
Traditional cardiovascular risk factors and their association with atherosclerotic cardiovascular disease in homozygous familial hypercholesterolemia: A cross-sectional analysis from the HICC registryWillemijn Am Schonck, G Kees Hovingh, Dirk J Blom, et al.
European Heart Journal|May 18, 2026
Homozygous familial hypercholesterolaemia: insights from the Global HICC RegistryWillemijn A M Schonck, Janneke W C M Mulder, Marina Cuchel, et al.
Journal of Cachexia, Sarcopenia and Muscle|August 15, 2022
Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)Peter E Penson, Eric Bruckert, David Marais, et al.
Plos One|June 4, 2021
Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH RegistryKhalid F Alhabib, Khalid Al-Rasadi, Turky H Almigbal, et al.
Current Vascular Pharmacology|October 6, 2018
The Gulf Familial Hypercholesterolemia Registry (Gulf FH): Design, Rationale and Preliminary ResultsKhalid Al-Rasadi, Khalid F Alhabib, Faisal Al-Allaf, et al.
Atherosclerosis. Supplements|December 13, 2016
Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration, Antonio J Vallejo-Vaz, Asif Akram, et al.
European Journal of Preventive Cardiology|May 14, 2026
Global survey of genetic testing methods for familial hypercholesterolemia. A study and recommendations from the EAS FHSC registryJoana Rita Chora, Irene Karungi, Amany Elshorbagy, et al.
Atherosclerosis|October 2, 2018
Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC), Antonio J Vallejo-Vaz, Martina De Marco, et al.
European Heart Journal|January 13, 2025
Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registryAmany Elshorbagy, Antonio J Vallejo-Vaz, Fotios Barkas, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Current Vascular Pharmacology|March 7, 2022
Identification of Novel and Known LDLR Variants Triggering Severe Familial Hypercholesterolemia in Saudi FamiliesFahad Alnouri, Faisal A Al-Allaf, Mohammad Athar, et al.
Atherosclerosis|March 28, 2026
Traditional cardiovascular risk factors and their association with atherosclerotic cardiovascular disease in homozygous familial hypercholesterolemia: A cross-sectional analysis from the HICC registryWillemijn Am Schonck, G Kees Hovingh, Dirk J Blom, et al.
European Heart Journal|May 18, 2026
Homozygous familial hypercholesterolaemia: insights from the Global HICC RegistryWillemijn A M Schonck, Janneke W C M Mulder, Marina Cuchel, et al.
Journal of Cachexia, Sarcopenia and Muscle|August 15, 2022
Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)Peter E Penson, Eric Bruckert, David Marais, et al.
Plos One|June 4, 2021
Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH RegistryKhalid F Alhabib, Khalid Al-Rasadi, Turky H Almigbal, et al.
Current Vascular Pharmacology|October 6, 2018
The Gulf Familial Hypercholesterolemia Registry (Gulf FH): Design, Rationale and Preliminary ResultsKhalid Al-Rasadi, Khalid F Alhabib, Faisal Al-Allaf, et al.
Atherosclerosis. Supplements|December 13, 2016
Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration, Antonio J Vallejo-Vaz, Asif Akram, et al.
European Journal of Preventive Cardiology|May 14, 2026
Global survey of genetic testing methods for familial hypercholesterolemia. A study and recommendations from the EAS FHSC registryJoana Rita Chora, Irene Karungi, Amany Elshorbagy, et al.
Atherosclerosis|October 2, 2018
Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC), Antonio J Vallejo-Vaz, Martina De Marco, et al.
European Heart Journal|January 13, 2025
Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registryAmany Elshorbagy, Antonio J Vallejo-Vaz, Fotios Barkas, et al.
Pageof 2